Northshore Clinical Laboratories INC

Northshore Clinical Laboratories INC was paid $10.79M by Medicaid between Jan 2018 and Nov 2022, across 17 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 59% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Illinois

Rank by total paid#16 of 235

Median peer was paid$123K

This provider vs. median88×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	2,682	$20K
2019	2,403	$15K
2020	3,718	$127K
2021	168,751	$6.32M
2022	106,901	$4.31M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	59%	93,489	48,955	$6.41M
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	16%	82,595	45,402	$1.68M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	13%	63,822	35,261	$1.40M
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	11%	35,462	27,103	$1.19M
86769		<1%	1,718	1,065	$65K
84443	Thyroid stimulating hormone (TSH)	<1%	863	760	$13K
80053	Comprehensive metabolic panel	<1%	1,359	1,222	$13K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	1,557	1,392	$8K
80061	Lipid panel	<1%	1,396	1,187	$7K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,116	948	$6K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	51	51	$2K
81003		<1%	899	675	$2K

5 more codes

82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	55	$370.68
82607		<1%	12	$123.60
84480		<1%	12	$92.87
83735		<1%	12	$58.07
36415	Collection of venous blood by venipuncture	<1%	37	$12.30

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMOHINDRA, MEENA (OWNER)